"Conditions and Diseases"

Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis

Yoga
webmaster
Tuesday, December 24, 2024
SOUKYA embarks on global journey with INR 220 Cr Investment in Portugal


Public Health Initiatives by Takeda to Strengthen Health System for Rare Diseases in India


to
webmaster
Monday, September 02, 2024
Best Agrolife Ltd. Receives Patent for Novel Ternary Pesticide Formulation to Combat Major Paddy Pests and Diseases
